194 participants
Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03 (NCT01272180)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2016-10-25
- Start Date:
- 2013-12-31
- Completion:
- 2014-05-31
Conditions
- Meningococcal Disease
Interventions
- BIOLOGICAL